Cynata Therapeutics Limited (FRA:51S)

Cynata Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 2, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	53	19	33	14	34	46
Market Cap Growth	87.46%	-42.66%	141.05%	-59.73%	-25.70%	4.38%
Enterprise Value	50	13	26	4	16	30
Last Close Price	0.24	0.06	0.15	0.05	0.22	0.27
PS Ratio	50.52	17.98	22.88	13.57	6.64	46.80
PB Ratio	15.92	5.67	7.34	1.34	2.15	2.55
P/TBV Ratio	15.92	5.67	7.34	1.34	2.15	2.55
EV/Sales Ratio	46.45	12.41	18.06	3.65	3.19	30.68
Asset Turnover	0.24	0.24	0.17	0.07	0.28	0.07
Quick Ratio	4.24	4.24	5.39	7.30	9.23	16.71
Current Ratio	4.40	4.40	5.58	7.46	9.33	17.03
Return on Equity (ROE)	-142.29%	-142.29%	-81.37%	-70.17%	-20.81%	-34.05%
Return on Assets (ROA)	-77.08%	-77.08%	-46.70%	-40.86%	-13.42%	-19.85%
Return on Capital (ROIC)	-91.02%	-91.02%	-53.39%	-45.73%	-14.49%	-20.85%
Return on Capital Employed (ROCE)	-160.70%	-160.70%	-141.70%	-89.00%	-25.30%	-26.60%
Earnings Yield	-9.86%	-27.71%	-18.39%	-63.59%	-10.56%	-10.63%
Buyback Yield / Dilution	-14.10%	-14.09%	-23.80%	-1.27%	-9.85%	-24.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.